View 
FILTERS (0)
* Not connected to ResearchPool

MORE FILTERS

  
reports
 PRESS RELEASE

“NASDAQ JAPAN IR EVENT” to Be Held at Nasdaq MarketSite on June 20, 20...

“NASDAQ JAPAN IR EVENT” to Be Held at Nasdaq MarketSite on June 20, 2024 Discover the appeal of Japanese companies listed in the U.S. NEW YORK, May 20, 2024 (GLOBE NEWSWIRE) -- MEDIROM Healthcare Technologies Inc. (NasdaqCM: MRM), a holistic healthcare company based in Japan (“MEDIROM”, the “Company”), today announced it will participate in a “NASDAQ JAPAN IR EVENT” to be held at Nasdaq MarketSite in Times Square on June 20, 2024. Five companies are currently expected to join this event (including one private company), and we will share information about the attractive nature of the Jap...

Maine Municipal Bond Bank: Update to credit analysis

Detailed credit opinion highlighting healthy reserve position, strong oversight and ongoing credit review of all program participants and support from the State of Maine.

Moody's Ratings affirms Banco BV's Ba2 deposit and debt ratings; stabl...

Moody's Ratings (Moody's) has today affirmed all ratings and assessments assigned to Banco BV (BV), including the bank's Ba2/Not Prime long and short-term local and foreign currency deposit ratings as well as its foreign currency senior unsecured debt, senior unsecured MTN Program and other short te...

Moody's Ratings says Crescent's announced acquisition does not current...

Moody's Ratings (Moody's) commented that Crescent Energy Finance LLC's (Crescent) announced acquisition of SilverBow Resources, Inc. (SilverBow, unrated) does not currently affect its ratings, including Crescent's Ba3 Corporate Family Rating (CFR) and B1 senior unsecured notes' ratings, or the stabl...

 PRESS RELEASE

Chemed Corporation Holds Annual Meeting of Stockholders; Board Declare...

CINCINNATI--(BUSINESS WIRE)-- Stockholders of Chemed Corporation (NYSE:CHE) today elected a slate of 10 directors at the Company’s 2024 annual stockholders’ meeting. Stockholders ratified the continuation of PricewaterhouseCoopers LLP as the Company’s independent accountants for 2024. Stockholders also approved Chemed’s executive compensation. In addition, stockholders voted against the stockholder proposal on ratification of termination pay. Dividend Declared Following the stockholders’ meeting, Chemed’s Board of Directors declared a quarterly cash dividend of 40 cents per share on the ...

Moody's Ratings upgrades Maine Municipal Bond Bank GOs rating to Aa1; ...

Moody's Ratings (Moody's) has upgraded the outstanding general obligation debt of the Maine Municipal Bond Bank to Aa1 from Aa2. The outlook has consequently been revised to stable from positive. The upgrade reflects Moody's upgrade of the State of Maine to Aa1 on May 15, 2024. RATINGS RATIONALE...

Carteret County, NC: Update to credit analysis

Moody's credit view highlighting Carteret County's tourism-centered economy, strong financial position, and low leverage.

Exmoor Funding 2024-1 Plc: Pre-Sale – LiveMore to issue owner occupied...

Our credit view of the transaction, including our analysis of the assets and the securitisation structure.

Moody's Ratings assigns Baa3 to Entergy Corp's junior subordinated deb...

Moody's Ratings (Moody's) today assigned a Baa3 rating to Entergy Corporation's (Entergy) (Baa2 stable) Junior Subordinated Debentures. The outlook for Entergy is stable. RATINGS RATIONALE The Baa3 rating assigned to Entergy's Junior Subordinated Debentures reflects the security's relative posit...

 PRESS RELEASE

Korro Presents Additional Preclinical Data for KRRO-110 at the America...

Korro Presents Additional Preclinical Data for KRRO-110 at the American Thoracic Society 2024 International Conference KRRO-110 showed sustained editing efficiency of approximately 60% and increased total alpha-1 antitrypsin (AAT) protein levels to greater than 60uM at week 13 in an in vivo genetic Alpha-1 Antitrypsin Deficiency (AATD) mouse modelKRRO-110 showed 35µM of M-AAT one week post the first dose, with 0µM of M-AAT at baseline, increasing to 45µM of M-AAT at week 13 CAMBRIDGE, Mass., May 20, 2024 (GLOBE NEWSWIRE) --  Korro Bio, Inc. (Korro) (Nasdaq: KRRO), a biopharmaceutical com...

Minnesota State Colleges & Universities, MN: Update to credit analysis

Our credit view of this issuer reflects its status as a largest provider in Minnesota of higher education, constrained by its pension plan obligations.

 PRESS RELEASE

$146.5 Million Inland Empire Multifamily Sale Closed By Marcus & Milli...

MURRIETA, Calif.--(BUSINESS WIRE)-- , a division of , announced the sale of Silverado Apartment Homes, a 492-unit multifamily property in Murrieta, California. The property sold for $146.5 million, which equates to $297,764 per unit. “Silverado presented a unique opportunity to acquire a newer vintage Inland Empire asset with substantial upside in a burgeoning submarket with strong fundamentals,” said Kevin Green, IPA executive managing director investments. “Our controlled process was met with a positive response and yielded a highly competitive sales environment. The opportunity was bolste...

 PRESS RELEASE

Axway Software : Déclaration des transactions sur actions propres

PARIS--(BUSINESS WIRE)-- Regulatory News: Dans le cadre de l’autorisation consentie par l’Assemblée Générale mixte du 16 mai 2024 pour la mise en œuvre d’un programme de rachat d’actions, Axway Software SA (Paris:AXW) (LEI : 96950022O6SP7FQONJ77) déclare ci-après les achats d’actions propres (FR0011040500) réalisés du 13 au 17 mai 2024 : Jour de latransaction Volume total journalier(nombre de titres) Prix pondérémoyen d'acquisition(€/action) Montant destransactions(€) Code identifiantmarché 13/05/2024 810 24.99 20,241 XPAR 14/05/2024 733 24.73 18,1...

Synaptics, Inc.: Update to credit analysis

Our credit view of this issuer reflects its niche market leadership positions and consistently positive FCF generation, against its small revenue scale.

Moody's Ratings assigns A3 rating to PayPal's proposed senior unsecure...

Moody's Ratings (Moody's) assigned an A3 rating to PayPal Holdings, Inc.'s (PayPal) proposed senior unsecured notes. The ratings outlook is stable. The net proceeds of the offering will be used for general corporate purposes including prefunding senior notes maturing October 1, 2024. RATINGS RATIO...

 PRESS RELEASE

Press Release: Dupixent® late-breaking data from NOTUS confirmatory ph...

Press Release: Dupixent® late-breaking data from NOTUS confirmatory phase 3 COPD study presented at ATS and published in NEJM   Dupixent® late-breaking data from NOTUS confirmatory phase 3 COPD study presented at ATS and published in NEJM NOTUS results confirm landmark data from the phase 3 BOREAS study and show Dupixent significantly reduced exacerbations by 34% and improved lung function, compared to placebo, in uncontrolled chronic obstructive pulmonary disease (COPD) with evidence of type 2 inflammationData support the potential of Dupixent as the first new treatment approach in mo...

 PRESS RELEASE

Communiqué de presse : Présentation à l’ATS et publication dans le NEJ...

Communiqué de presse : Présentation à l’ATS et publication dans le NEJM des données de dernière heure de l’étude confirmatoire de phase III NOTUS relative à Dupixent® dans le traitement de la BPCO Présentation à l’ATS et publication dans le NEJM des données de dernière heure de l’étude confirmatoire de phase III NOTUS relative à Dupixent® dans le traitement de la BPCO Les résultats de l’étude NOTUS confirment les données décisives de l’étude de phase III BOREAS et montrent que, dans le traitement de la bronchopneumopathie chronique obstructive (BPCO) avec signature inflammatoire de ty...

 PRESS RELEASE

Dupixent® (dupilumab) Late-Breaking Data from NOTUS Confirmatory Phase...

Dupixent® (dupilumab) Late-Breaking Data from NOTUS Confirmatory Phase 3 COPD Trial Presented at ATS and Published in The New England Journal of Medicine NOTUS results confirm landmark data from the Phase 3 BOREAS trial and show Dupixent significantly reduced exacerbations by 34% and improved lung function, compared to placebo, in uncontrolled chronic obstructive pulmonary disease (COPD) with evidence of type 2 inflammation Data support the potential of Dupixent as the first new treatment approach in more than a decade and first-ever targeted therapy for COPD TARRYTOWN, N.Y. and PARIS...

Xianhe Co Ltd: 1 director

A director at Xianhe Co Ltd maiden bought 1,110,000 shares at 19.853CNY and the significance rating of the trade was 100/100. Is that information sufficient for you to make an investment decision? This report gives details of those trades and adds context and analysis to them such that you can judge whether these trading decisions are ones worth following. Included in the report is a detailed share price chart which plots discretionary trades by all the company's directors over the last two ye...

 PRESS RELEASE

HP Unlocks New Era of AI Experiences Powering Work and Creation

HP Unlocks New Era of AI Experiences Powering Work and Creation World’s most powerful and secure ultra-mobile AI PCs drive next generation of AI computing with record-breaking 26 hours of battery life 1, 2, 3 News Highlights: World’s most powerful ultra-mobile next-gen AI PCs1 reclaim time for meaningful work and creationUnleash your full potential from anywhere with the world’s longest battery life in an ultra-mobile next-gen AI PC3Sleek new HP next-gen AI PCs deliver lightning-fast responsiveness with a dedicated NPU4 capable of 45 trillion operations per second (TOPS)Discover new AI su...

Loading...
New interest

Save your current filters as a new Interest

Please enter a name for this interest

Email alerts

Would you like to receive real-time email alerts when a new report is published under this interest?

Save This Search

These search results will show up under 'Saved searches' in the left panel

Please enter a name for this saved search

ResearchPool Subscriptions

Get the most out of your insights

Get in touch